Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens

Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients

(2016) A. Padullés et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

(2014) Heather E. Vezina et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian

(2013) Tatiana Tatarinova et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R

(2012) Michael N. Neely et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus

(2009) A. Caldes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Valganciclovir in Adult Solid Organ Transplant Recipients

(2009) Nancy Perrottet et al.   CLINICAL PHARMACOKINETICS